Neutrogena is recalling some of its popular makeup wipes due to possible bacterial contamination.
The recall covers 1,312 cases of Neutrogena's "Makeup Remover Ultra-Soft Cleansing Towelettes" after testing revealed the presence of pluralibacter gergoviae, a bacterium known to cause infections in certain people, according to the U.S. Food and Drug Administration (FDA).
The affected products were distributed to several states, including Texas, South Carolina, Georgia and Florida, and carry the lot number 1835U6325A, the agency said.
HORMEL RECALLS 4.9M POUNDS OF CHICKEN POSSIBLY 'CONTAMINATED WITH PIECES OF METAL'
Pluralibacter gergoviae can lead to serious infections in individuals with weakened immune systems, chronic health conditions or those undergoing surgery, according to the National Institutes of Health (NIH).
COCA-COLA RECALLS 3 POPULAR SODAS OVER POTENTIAL FOREIGN MATERIAL CONTAMINATION
"The good news is the overwhelming majority of the population, this bacteria poses no harm whatsoever," Fox News contributor Dr. Nicole Saphier said on "Fox & Friends Weekend" on Sunday. "It's really for those who are immunocompromised.
She pointed out that the FDA classified this as a Level Two safety recall, meaning the "danger is very minimal."
EGG RECALL OVER SALMONELLA CONCERNS EXPANDS
"We see these recalls in a lot of cosmetics all the time," Saphier said.
Saphier noted that these types of bacteria are naturally found in soil and water.
She also encouraged consumers to be mindful when applying products to their face when they have any kind of open wound.
"It's most likely going to be safe, but you could still be exposing yourself to bacterial infections," Saphier said.
The recall comes amid a wave of recent product recalls across major brands.
Over the summer, DermaRite Industries similarly announced it was recalling products including hand soap, deodorant, lotions, shampoo and hand sanitizer due to concerns over bacterial contamination, according to the FDA.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
Neutrogena and the FDA did not immediately respond to FOX Business' request for comment.
